Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Javier Enrique Cruz Herrera"'
Autor:
José Antonio Mata-Marín, Moisés Hermilo Martínez-Osio, Carla I. Arroyo-Anduiza, María de los Ángeles Berrospe-Silva, Alberto Chaparro-Sánchez, Itzel Cruz-Grajales, Javier Enrique Cruz-Herrera, Luis Antonio Uribe-Noguez, Jesus E. Gaytán-Martínez, Medardo Jerónimo-Morales
Publikováno v:
BMC Research Notes, Vol 12, Iss 1, Pp 1-6 (2019)
Abstract Objective This study was to determine and compare the prevalences of polypharmacy and comorbidities in patients aged 50 years or older with those patients younger than 50 years in a Mexican population. Results One hundred and twenty-five pat
Externí odkaz:
https://doaj.org/article/3a84bc1e9e3e4735949a9157683dbc96
Autor:
Moisés Hermilo Martínez-Osio, Alberto Chaparro-Sánchez, Luis Antonio Uribe-Noguez, Carla Ileana Arroyo-Anduiza, Jesús Gaytán-Martínez, Itzel Cruz-Grajales, Medardo Jerónimo-Morales, José Antonio Mata-Marín, Javier Enrique Cruz-Herrera, María de los Ángeles Berrospe-Silva
Publikováno v:
BMC Research Notes, Vol 12, Iss 1, Pp 1-6 (2019)
BMC Research Notes
BMC Research Notes
Objective This study was to determine and compare the prevalences of polypharmacy and comorbidities in patients aged 50 years or older with those patients younger than 50 years in a Mexican population. Results One hundred and twenty-five patients wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::131dd37ef97219838326196d85127354
http://link.springer.com/article/10.1186/s13104-019-4576-6
http://link.springer.com/article/10.1186/s13104-019-4576-6
Autor:
Gloria Huerta García, Marcelino Chavez-García, Nohemí Nuñez-Rodríguez, José Antonio Mata-Marín, Alfredo Villagómez-Ruiz, Jesús Gaytán-Martínez, Bulmaro Manjarrez-Tellez, Jorge Luis Sandoval-Ramírez, Juan Carlos Domínguez-Hermosillo, Javier Enrique Cruz-Herrera, Marco Issac Banda-Lara
Publikováno v:
Journal of infection in developing countries. 10(6)
Introduction: Treatment options are limited for HIV-1-infected individuals who have received extensive previous antiretroviral therapy. ETV has shown significant clinical benefits in treatment-experienced HIV-1+ patients with antiretroviral resistanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca9c627207bfeca88343c8b530a7218b
https://pubmed.ncbi.nlm.nih.gov/27367009
https://pubmed.ncbi.nlm.nih.gov/27367009
Autor:
Nohemí Nuñez-Rodríguez, Alfredo Villagómez-Ruiz, Juan Carlos Domínguez-Hermosillo, Ivan Martínez-Abarca, Marco Isaac Banda-Lara, Jesús Gaytán-Martínez, José Antonio Mata-Marín, Marcelino Chavez-García, Gloria Huerta-García, Javier Enrique Cruz-Herrera, Bulmaro Manjarrez-Tellez, Jorge Luis Sandoval-Ramírez
Publikováno v:
AIDS Research and Therapy
Objective We evaluated the effectiveness of darunavir (DRV) treatment plus an optimized background regimen in 120 HIV-1 treatment-experienced patients. Design Retrospective cohort, multicenter study. Methods Adults >16 years with virological treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0298a7f23cd3a1530425d262ebb3a101
https://pubmed.ncbi.nlm.nih.gov/26413132
https://pubmed.ncbi.nlm.nih.gov/26413132
Autor:
Bulmaro Manjarrez-Tellez, Rocío Zapata-López, Marco Isaac B, Nohemí Nuñez-Rodríguez, Juan Carlos Domínguez-Hermosillo Juan, Jesús Gaytán-Martínez, Marcelino Chavez-García, Gloria Huerta-García, Jorge S, oval-Ramirez, José Antonio Mata-Marín, a-Lara, Corina Ortega-Ortiz, Javier Enrique Cruz Herrera
Publikováno v:
Journal of AIDS & Clinical Research.
Background: People infected with human immunodeficiency virus (HIV) develop lipid and glucose metabolic alterations, which predisposes them to cardiovascular disease. The aim of this study was to evaluate the cumulative incidence of dyslipidemia and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26ff3a827ed8eb85f8e5c0d010ae5d1e
https://doi.org/10.4172/2155-6113.1000533
https://doi.org/10.4172/2155-6113.1000533
Autor:
Ariane Estrella Weiser Smeke, Alma Minerva Pérez Rios, Mariana Rotzinger Rodriguez, Javier Enrique Cruz Herrera, Marco Isaac Banda-Lara, Alberto Chaparro Sánchez, José Antonio Mata-Marín, Marcelino Chavez-García, Jesús Gaytán-Martínez, Nohemí Nuñez-Rodríguez, Irene Juarez-Kasusky, Juan Carlos Domínguez-Hermosillo, Jorge Luis Sandoval Ramírez
Publikováno v:
Drugs in R&D
Objective We evaluated the effectiveness of a raltegravir (RAL)-containing regimen plus an optimized background regimen in HIV-1 highly treatment-experienced patients. Design A retrospective cohort, multicentre study was conducted. Methods Adult (>16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::437651b76c139c2e9b9e35c1449b2d9b